KSMO 2024

Ono Pharmaceutical Korea Co., Ltd./ Bristol-Myers Squibb Company

-ONO focuses on drug discovery leads that are high in certainty and globally competitive. Capitalizing on the technologies and know-how nurtured through our research history, we propel drug development in areas where we can continue to optimize our strengths and in areas where we can effectively utilize the genes we possess as our genetic assets in the field of genomic drug discovery. We are in active pursuit of the discovery and development of drugs that meet the unmet medical needs at the frontline of healthcare. By strengthening strategic alliances globally, we endeavor to bolster our drug discovery capability, introducing breakthrough drug discovery seeds and leading-edge technologies from biopharmaceutical companies, as well as academic and other research establishments. We are constantly expanding our development pipeline, directing our efforts toward licensing activities such as the in-licensing of new drug candidates.-Bristol Myers Squibb At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. We are in the business of breakthroughs - the kind that transform patients’ lives through life-saving, innovative medicines. We have the most talented people in the industry who come to work every day dedicated to our mission of discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – we focus on innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. With great pride, we celebrate each time our patients take back their lives. Our shared values are central to who we are, what we do and how we do it. Passion, innovation, urgency, accountability, inclusion and integrity ground our work and unite our community. We never give up in our search for the next innovation that could mean new hope for patients who are urgently seeking new treatment options today. Our symbol, the hand, is a simple, universal expression of healing, of giving and receiving care. It is a representation of humanity, of the personal touch we bring to our work and to every treatment we pioneer. Our brand fully embodies our vision, and embraces our commitment to compassionate science and putting patients and people first. NO-KR-2100004/May2021